flavin-adenine-dinucleotide has been researched along with Carcinoma--Renal-Cell* in 1 studies
1 other study(ies) available for flavin-adenine-dinucleotide and Carcinoma--Renal-Cell
| Article | Year |
|---|---|
Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.
Topics: Antineoplastic Agents; Binding Sites; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavin-Adenine Dinucleotide; Histone Demethylases; Humans; Kidney Neoplasms; Molecular Docking Simulation; Raloxifene Hydrochloride | 2021 |